Ina Park, MD

Associate Professor,
Family Community Medicine
+1 510 620-3400

As a UCSF faculty member I am honored to demonstrate my interest for STIs through research, teaching, and patient care. I currently serve as the Medical Director for the California Prevention Training Center and am the site PI for the multicenter CDC-funded HPV-Impact project,which monitors the population-level effects of HPV vaccination.

Nationally I am proud to serve as a medical consultant to the CDC Division of STD Prevention and recently co-authored the 2020 CDC STI Treatment Guidelines. I also served as a committee member of the HHS's first Federal STI Action Plan and serving a two year term with the Planned Parenthood Foundation of America National Medical Committee.

Currently my passions lie in using storytelling and public engagement to fight the lingering stigma towards STIs. My first book for the lay public is entitled Strange Bedfellows: Adventures in the Science, History, and Surprising Secrets of STIs. (Macmillan Feb 2021) Read more about me and the book here: www.inapark.net

Publications: 

Improved gonorrhea and chlamydia testing among men who have sex with men living with HIV through implementation of self-collected tests.

Sexually transmitted diseases

Ina U. Park, Dominique Reminick, Jeffrey M. Schapiro, Leo B. Hurley, Charles Brad Hare, Sally Slome, Jason A. Flamm, Alexandra Anderson, Michael J. Silverberg, Michael W. Allerton

A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea.

Sexually transmitted diseases

Levy V, Pandori M, Berrada ZL, Relucio KI, Lopez TP, Samuel MC, Park IU

Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Park IU, Introcaso C, Dunne EF

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.

Vaccine

Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW, Abdullah N, Levine D, Johnson ML, Steinau M, Markowitz LE

A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening.

American journal of obstetrics and gynecology

Patanwala IY, Bauer HM, Miyamoto J, Park IU, Huchko MJ, Smith-McCune KK

Reverse sequence serologic screening for syphilis with treponemal tests--United States, 2006-2010

Morbidity and Mortality Weekly Report

Radolf J, Bolan G, Park I, Chow JM, Schillinger JA, Pathela P

Retesting for repeat chlamydial infection: family planning provider knowledge, attitudes, and practices.

Journal of women's health (2002)

Park IU, Amey A, Creegan L, Barandas A, Bauer HM

Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia.

Gynecologic oncology

Park IU, Ogilvie JW, Anderson KE, Li ZZ, Darrah L, Madoff R, Downs L

Anal dysplasia in kidney transplant recipients.

Journal of the American College of Surgeons

Ogilvie JW, Park IU, Downs LS, Anderson KE, Hansberger J, Madoff RD

Cervical cancer prevention in the developing world.

Journal of lower genital tract disease

Park IU, Diaz ML, Bowey C, Magaril R, Ferris DG

Initiating the American Society for Colposcopy and Cervical Pathology Humanitarian Program: Peru 2005.

Journal of lower genital tract disease

Ferris DG, Park I, Waxman A, Joste N, Magaril RA, Greenspan D, Santos C, Galdos O, Velarde C, Bautista F, Salazar R, Tatti SA

Correlates of HIV risk among Ecuadorian adolescents.

AIDS education and prevention : official publication of the International Society for AIDS Education

Park IU, Sneed CD, Morisky DE, Alvear S, Hearst N

Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram.

The Journal of pharmacology and experimental therapeutics

Chiu N, Park I, Reid IA